Palvella Therapeutics PVLA
NASDAQ PVLA
$132.73 -5.20 (-3.77%)
At close: Oct 1, 2026 · 4:00 PM EDT

Palvella Therapeutics (PVLA) Other Operating Expenses (2013 - 2023)

Updated

Palvella Therapeutics' Other Operating Expenses came in at -$14.89 million for Q4 2023.

Analysis

Palvella Therapeutics (PVLA) Other Operating Expenses (2013 - 2023) Analysis & Trends

For FY2023, Palvella Therapeutics' Other Operating Expenses was $23.1 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Palvella Therapeutics 1.99 Bn 1.73 Bn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 -14.89 Mn
Sep 30, 2023 14.89 Mn
Sep 30, 2014 13,900.00
Dec 31, 2013 36.00
Sep 30, 2013 5,750.00
API Access

Palvella Therapeutics Other Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-operating-expenses&ticker=PVLA&period=max&api_key=YOUR_API_KEY